Literature DB >> 2630328

Initial clinical experience using a diode laser in the treatment of retinal vascular disease.

J D McHugh1, J Marshall, T J Ffytche, A M Hamilton, A Raven, C R Keeler.   

Abstract

A pilot study has been carried out to investigate the clinical use of an infrared diode laser in the treatment of a number of retinal vascular conditions. A hand-held device was employed initially and subsequently a further prototype was developed for use in conjunction with a standard slit lamp microscope. Thirty-three eyes in thirty patients were treated for conditions such as proliferative diabetic retinopathy, exudative retinopathy and branch and central retinal vein thrombosis. Regression of neovascularisation was observed in 13 of 16 eyes (81%) with proliferative diabetic retinopathy and in six of eight eyes (75%) with branch retinal vein occlusion. Four eyes were successfully treated for established or incipient rubeosis iridis following central vein thrombosis. Focal photocoagulation applied to five eyes for diabetic exudative maculopathy resulted in partial resorption of the exudates. These results are presented together with information on the ease of use of the laser and its reliability. The implications of the development of this instrument in the context of its place in ophthalmic therapy are discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2630328     DOI: 10.1038/eye.1989.83

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  15 in total

1.  Diode laser trabeculoplasty (DLT) for primary open-angle glaucoma and ocular hypertension.

Authors:  D McHugh; J Marshall; T J Ffytche; P A Hamilton; A Raven
Journal:  Br J Ophthalmol       Date:  1990-12       Impact factor: 4.638

2.  Iris clipping of a diode laser beam when performing retinal photocoagulation.

Authors:  W H Woon; T J ffytche; A M Hamilton; J Marshall
Journal:  Br J Ophthalmol       Date:  1991-07       Impact factor: 4.638

3.  Field loss after pan retinal photocoagulation with diode and argon lasers.

Authors:  S Buckley; L Jenkins; L Benjamin
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

4.  The safety of laser pointers: myths and realities.

Authors:  J Marshall
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

5.  The 2014 Bowman Lecture-Bowman's and Bruch's: a tale of two membranes during the laser revolution.

Authors:  J Marshall
Journal:  Eye (Lond)       Date:  2015-01       Impact factor: 3.775

6.  Diode versus argon-green laser panretinal photocoagulation in proliferative diabetic retinopathy: a randomized study in 44 eyes with a long follow-up time.

Authors:  F Bandello; R Brancato; G Trabucchi; R Lattanzio; A Malegori
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-09       Impact factor: 3.117

7.  Continuous wave Nd:YAG laser photocoagulation in proliferative diabetic retinopathy.

Authors:  U Menchini; P Lanzetta; F Soldano; E Ferrari; G Virgili
Journal:  Br J Ophthalmol       Date:  1995-07       Impact factor: 4.638

8.  Photocoagulation of choroidal neovascular membranes with a diode laser.

Authors:  M W Ulbig; D A McHugh; A M Hamilton
Journal:  Br J Ophthalmol       Date:  1993-04       Impact factor: 4.638

9.  Subthreshold micropulse diode laser treatment in diabetic macular oedema.

Authors:  M L Laursen; F Moeller; B Sander; A K Sjoelie
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

10.  Diode laser contact transscleral retinal photocoagulation: a clinical study.

Authors:  D A McHugh; S Schwartz; J G Dowler; M Ulbig; R K Blach; P A Hamilton
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.